MYND Life Sciences Inc. reported earnings results for the first quarter ended January 31, 2023. For the first quarter, the company reported net loss was CAD 0.8385 million compared to CAD 1.31 million a year ago. Basic loss per share from continuing operations was CAD 0.02 compared to CAD 0.03 a year ago.
Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
0.04 CAD | +100.00% | 0.00% | 0.00% |
1st Jan change | Capi. | |
---|---|---|
0.00% | 698K | |
+16.75% | 122B | |
+20.57% | 115B | |
+21.22% | 26.64B | |
-22.87% | 19.91B | |
-17.17% | 16.32B | |
-45.95% | 15.52B | |
-19.33% | 15.49B | |
+60.99% | 14.83B | |
+2.39% | 13.67B |
- Stock Market
- Equities
- MYND Stock
- News MYND Life Sciences Inc.
- MYND Life Sciences Inc. Reports Earnings Results for the First Quarter Ended January 31, 2023